FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

HESTERBIO Share Price Discussion

Hester Biosciences Ltd.
NSE: HESTERBIO | BSE: 524669 | ISIN: INE782E01017 | Sector: Pharmaceuticals and health care

HESTERBIO Rating

0/5 (0 Ratings)
HESTERBIO Share Price *
960 +13.85 (1.46%)
* (quote may be delayed)
Find answers to all your questions on live HESTERBIO message board: Is HESTERBIO buy or sell? Should I buy HESTERBIO shares? Why are HESTERBIO shares falling? Should I invest in HESTERBIO stock?

You can also check HESTERBIO share price target recommended by brokerages.

HESTERBIO Discussion Forum

HESTERBIO

Type
Buy
Instrument
HESTERBIO
Entry Price
₹1,470
Price@Trade
₹1,470
Target Price
₹2,280
Stop Price
₹1,290
Valid Till
Mar 2, 2021 3:20 AM
Margin
₹1,470 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹1,290
Net P&L
-12.24% Loss
INVESTMENT
BUY HESTERBIO SCIENCE cmp 1465-70 sl 1290 tgt 2281-2625-3600
Like
reply
Reply (2)
Latest replies

INVESTMENT
BUY HESTERBIO SCIENCE cmp 1465-70 sl 1290 tgt 2281-2625-3600
TrackerBot @trackerbot
Mar 12 2:46 AM

Update
Stoploss Hit
Exit Price
₹1,290
The Inside Guy in HESTERBIO
*Investment call* Buy *Hester bio sciences* c...

*Positive accumulated happened last month* price closed above 1514, Monthly support . Cmp 1574(-60) target 1878-2171-2284-2464-2625-3600 Running. ✌️✌️
1
reply
Reply
HESTERBIO

Type
Buy
Instrument
HESTERBIO
Entry Price
₹1,454
Price@Trade
₹1,454
Target Price
₹1,600
Stop Price
₹1,400
Valid Till
Jan 1, 2021 3:20 AM
Margin
₹1,454 approx for 1 Qty
Status
Exited
Exit Price
₹1,494.6
Net P&L
2.79% Profit
Like
reply
Reply (1)
Latest replies

Update
Exited
Exit Price
₹1,494.6
Net P&L
2.79% Profit

BRIEF-Hester Biosciences Seeks Shareholders' Nod For Issuance Of Equity Shares Via Qualified Institutional Placement - Reuters
19-Dec-2019 10:29:43 AM
Dec 19 (Reuters) - Hester Biosciences Ltd HEST.NS:
HESTER BIOSCIENCES LTD - SEEKS SHAREHOLDERS' NOD FOR ISSUANCE OF EQUITY SHARES...
Read more...
Like
reply
Reply
@invictotrader • Reputation: -1,741

Hester Biosciences approves raising up to Rs 150cr via QIP, preferential allotment The board also approved reappointment of Rajiv Gandhi, CEO and Managing Director of the company, for a period of three years from April 1, 2020 to March 31, 2023, subject to approval of members thr...
Read more...
Like
reply
Reply
@invictotrader • Reputation: -1,741

Hester Biosciences Ltd board to consider fund raising through issue of equity shares
Like
reply
Reply

*Investment call*
Buy *Hester bio sciences* cmp 1630 SL 1300 (330) target 2363-3156-4440 *3 shares*
Like
reply
Reply (1)
Latest replies

*Positive accumulated happened last month* price closed above 1514, Monthly support . Cmp 1574(-60) target 1878-2171-2284-2464-2625-3600 Running. ✌️✌️
HALAL INVESTMENT
HESTER BIO...1694 BUY RANGE CMP 1680 TO 1640 PU...

HESTER BIO HIGH 1780....NEAR TARGET...HOLD ON...BK UR INVESTMENT AR 1810/1820
Like
reply
Reply
HALAL INVESTMENT
HESTER BIO...1694 BUY RANGE CMP 1680 TO 1640 PUT 1635 AS CBSL 4 SHRTTERM EXPECT TARGET 1750/1785+

HESTER BIO...IN BUY RANGE
Like
reply
Reply (3)
Latest replies
TAPAS GHOSH @tapasghosh
Aug 21 8:53 AM

sir hester hold ya sold

@tapasghosh gd support at 1613..my opinion hold..put 1613 stpls
TAPAS GHOSH @tapasghosh
Aug 21 8:57 AM

ok

HESTER BIO...1694
BUY RANGE CMP 1680 TO 1640
PUT 1635 AS CBSL 4 SHRTTERM
EXPECT TARGET 1750/1785+
Like
reply
Reply (1)
Latest replies
TAPAS GHOSH @tapasghosh
Aug 21 8:51 AM

sir hester hold ya sold
@newsbot • Reputation: 2,602
Like
reply
Reply
@newsbot • Reputation: 2,602
Like
reply
Reply
@newsbot • Reputation: 2,602
Like
reply
Reply
  • HESTERBIO - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,364.92
    Enterprise Value1,394.97
    Price to Earnings45.5
    Price to Book Value9.41
    Return on Capital Employed0.24
    Return on Equity0.21
    Face Value10
    Dividend Yield0.01
  • HESTERBIO Share Price - Technicals

    keyboard_arrow_down
    HESTERBIO - 52 Week High₹2,048
    HESTERBIO - 52 Week Low₹864
  • HESTERBIO - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    31-Oct-18ICICIdirect.comBuy1,620
    25-Jan-18ICICIdirect.comBuy1,930
    30-Nov-17Karvy Stock BrokingBuy1,417
    29-Mar-17ICICIdirect.comBuy1,040
    HESTERBIO Brokerage Price Target
  • HESTERBIO Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Apr 39501029.95927.8957.05
    Apr 1969.8969.85938.05946.15
    Mar 31942.1990.25910920.45
    Mar 30989.9989.9930.15941
    Mar 271050.951050.95965.05999.65
  • HESTERBIO Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹1,105.6
    30 Day Moving Average₹1,232.99
    50 Day Moving Average₹1,375.58
    100 Day Moving Average₹1,454
    200 Day Moving Average₹1,585.91
  • HESTERBIO - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue135123.220.1
    Operating Profit5040.940.22
    Profit Before Tax4332.940.31
    Net Income3024.840.21
  • HESTERBIO - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds145119.740.21
    Total Liabilities6563.960.02
    Total Assets212183.70.15
  • HESTERBIO - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity3127.10.14
    Cash from Investing Activity-26-15.490.68
    Cash from Financing Activity-5-5.14-0.03
    Net Cash FlowNA6.47-1
  • HESTERBIO - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.140.14
    Return on Equity0.210.21
    Return on Capital Employed0.240.23
  • HESTERBIO - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.5
    3 Year CAGR Growth in Operating Profit0.91
    3 Year CAGR Growth in EBIDTA0.72
    3 Year CAGR Growth in Net Income1.06
    3 Yr CAGR Growth - Diluted EPS1.03
  • HESTERBIO - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue1.07
    5 Year CAGR Growth in Operating Profit1.23
    5 Year CAGR Growth in EBIDTA1.21
    5 Year CAGR Growth in Net Income2.1
    3 Yr CAGR Growth - Diluted EPS2.09
  • HESTERBIO - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 19 3:38 AM
    NewsBot
    Dec 26 1:37 AM
    NewsBot
    Oct 31 9:42 AM
  • HESTERBIO - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. S...
    Aurobindo Pharma Ltd. Sector: Pharma...
    Biocon Ltd. Sector: Pharmaceuticals ...
    Cipla Ltd. Sector: Pharmaceuticals a...
    Dr. Reddy's Laboratories Ltd. Sector...
    Lupin Ltd. Sector: Pharmaceuticals an...
    Piramal Enterprises Ltd. Sector: Phar...
    Divi's Laboratories Ltd. Sector: Pha...
    Glenmark Pharmaceuticals Ltd. Sector...
    Strides Pharma Science Ltd. Sector: P...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.